These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 17350342
1. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy. Hessen E, Lossius MI, Reinvang I, Gjerstad L. Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342 [Abstract] [Full Text] [Related]
2. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy. Hessen E, Lossius MI, Reinvang I, Gjerstad L. Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701 [Abstract] [Full Text] [Related]
3. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Lossius MI, Hessen E, Mowinckel P, Stavem K, Erikssen J, Gulbrandsen P, Gjerstad L. Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074 [Abstract] [Full Text] [Related]
7. Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study. Lossius MI, Taubøll E, Mowinckel P, Gjerstad L. Epilepsy Behav; 2009 Sep; 16(1):64-8. PubMed ID: 19646931 [Abstract] [Full Text] [Related]
8. Effects of antiepileptic drugs on mood and behavior. Schmitz B. Epilepsia; 2006 Sep; 47 Suppl 2():28-33. PubMed ID: 17105456 [Abstract] [Full Text] [Related]
12. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. Koethe D, Juelicher A, Nolden BM, Braunwarth WD, Klosterkötter J, Niklewski G, Wodarz N, Klatt J, Burtscheidt W, Gaebel W, Markus Leweke F. Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748 [Abstract] [Full Text] [Related]
13. Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting. Arain A, Shihabuddin B, Niaz F, Modur P, Taylor H, Fakhoury T, Abou-Khalil B. Epilepsia; 2006 Dec; 47(12):2052-7. PubMed ID: 17201703 [Abstract] [Full Text] [Related]
14. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial. Togha M, Akhondzadeh S, Motamedi M, Ahmadi B, Razeghi S. Arch Med Res; 2007 Apr; 38(3):313-6. PubMed ID: 17350481 [Abstract] [Full Text] [Related]
16. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study. Herman I, Shamir D, Bar-Hamburger R, Pick CG, Schreiber S. Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125 [Abstract] [Full Text] [Related]
18. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Khan RB, Onar A. Epilepsia; 2006 Feb; 47(2):375-9. PubMed ID: 16499763 [Abstract] [Full Text] [Related]